Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2013-02, Vol.137 (3), p.903-913
Hauptverfasser:	Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Antioxidants Antioxidants - administration & dosage Antioxidants - therapeutic use Biological and medical sciences Breast cancer Breast Neoplasms - drug therapy Cancer Cancer research Cancer therapies Chemotherapy Clinical trials Dietary Supplements Epidemiology Female Folic acid Genital system. Mammary gland Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Medicine Medicine & Public Health Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Odds Ratio Oncology Product development Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Risk Factors Tumors Vitamins - administration & dosage Vitamins - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!